---

---

entities : Astrazeneca plc    symbols : Nvo   

save search

---

Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 3.69% | O: 0.24% H: 0.42% C: 0.42%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 3.3% | O: -0.84% H: 0.86% C: -0.62%
GSK | News | $40.73 -1.24% 360K |

Health Technology

| 4.14% | O: -0.56% H: 0.0% C: 0.0%
LLY | News | $731.46 -1.91% 700K |

Health Technology

| -1.56% | O: -0.21% H: 0.11% C: -3.05%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 3.79% | O: -0.18% H: 0.84% C: 0.6%
report reach therapeutics market

---

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 3.42% | O: 2.71% H: 0.36% C: 0.11%
LEXX | $2.24 33K |

Health Technology

| 65.93% | O: 0.0% H: 8.15% C: 1.48%
PFE | News 4 | $26.185 -0.51% 6.6M |

Health Technology

| -10.69% | O: -0.37% H: 1.09% C: 0.75%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 21.38% | O: 0.19% H: 0.34% C: 0.21%
MRK | $126.28 -0.47% 1.3M |

Health Technology

| 8.24% | O: 0.32% H: 0.26% C: -0.18%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 3.61% | O: 0.28% H: 0.99% C: 0.93%

---

Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -1.63% | O: 3.66% H: 0.0% C: -0.12%
AZNCF | News | $140.3 1.5K |

Health Technology

| 7.51% | O: 3.33% H: 0.0% C: -2.93%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 24.31% | O: -0.31% H: 0.39% C: -0.44%
JNJ | News | $147.27 -1.53% 2.3M |

Health Technology

| -2.51% | O: 1.09% H: 0.0% C: 0.0%
LLY | News | $731.46 -1.91% 700K |

Health Technology

| 29.2% | O: 0.18% H: 0.5% C: -0.46%
BMY | $48.64 -0.71% 2.3M |

Health Technology

| -4.43% | O: -0.78% H: 5.15% C: 2.81%
ABBV | News | $168.1 -0.85% 670K |

Health Technology

| 11.11% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -3.43% | O: 1.03% H: 0.0% C: 0.0%
REGN | News | $911.73 0.49% 97K |

Health Technology

| 7.77% | O: 0.52% H: 0.58% C: 0.05%
GILD | $66.55 -0.72% 1.6M |

Health Technology

| -15.08% | O: 0.34% H: 1.02% C: 0.59%
BIIB | $202.05 4.59% 1.1M |

Health Technology

| -23.9% | O: 0.57% H: 1.36% C: 1.04%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 6.86% | O: 1.06% H: 0.18% C: -1.06%
AMGN | News | $273.6 0.02% 370K |

Health Technology

| -2.07% | O: 0.24% H: 2.03% C: 1.49%
patent report global market

---

Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 5.89% | O: -3.0% H: 2.15% C: 2.15%
NVSEF | News | $96.0 52K |

Health Technology

| -2.04% | O: 0.0% H: 0.0% C: 0.0%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 31.27% | O: -0.48% H: 0.0% C: -0.44%
NVS | News | $97.515 0.24% 820K |

Health Technology

| -0.01% | O: -1.31% H: 0.56% C: -0.17%
LLY | News | $731.46 -1.91% 700K |

Health Technology

| 24.49% | O: -4.44% H: 0.0% C: 0.0%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -2.57% | O: -0.93% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 6.78% | O: -2.23% H: 0.28% C: -0.11%
reach research market

---

Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.82 -1.82% 510K |

Health Technology

| Email alert Add to watchlist
LLY | News | $731.46 -1.91% 700K |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| Email alert Add to watchlist
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.5K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 480 |

Health Technology

| Email alert Add to watchlist
report astrazeneca global market

---

Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
Published: 2023-10-23 (Crawled : 19:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| -55.56% | O: -44.44% H: 60.0% C: -20.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| 13.37% | O: 1.37% H: 1.36% C: 1.36%
VTRS | News A | $11.34 -0.18% 900K |

Health Technology

| 27.35% | O: 0.45% H: 2.46% C: 1.67%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 32.45% | O: -0.79% H: 1.41% C: 1.21%
LLY | News | $731.46 -1.91% 700K |

Health Technology

| 26.15% | O: -0.84% H: 0.0% C: 0.0%
BAX | $40.705 -0.77% 280K |

Health Technology

| 24.87% | O: 0.2% H: 0.9% C: -1.05%
ABT | News | $105.9 -1.57% 1.3M |

Health Technology

| 10.72% | O: -1.82% H: 0.0% C: 0.0%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -9.48% | O: 0.77% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 12.37% | O: 0.38% H: 2.31% C: 2.02%
report business global growth

---

Global Oral Proteins and Peptides Market Valued at $1.57 Billion in 2022, Driven by Rising Demand for Oral Treatments
Published: 2023-09-12 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 6.11% | O: 0.89% H: 0.37% C: -2.49%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 30.76% | O: -2.21% H: 1.23% C: 0.11%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 5.21% | O: -0.22% H: 0.33% C: -1.1%
global market

---

Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
AZNCF | News | $140.3 1.5K |

Health Technology

| -0.07% | O: 1.06% H: 0.72% C: 0.72%
RLYB | News | $1.705 -2.01% 83K |

| -69.51% | O: -0.34% H: 4.41% C: -5.25%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| -17.95% | O: -1.19% H: 1.41% C: 1.36%
CRL | News | $239.075 -0.44% 180K |

Commercial Services

| 16.72% | O: 0.09% H: 1.73% C: 1.58%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| -0.16% | O: -0.83% H: 0.89% C: 0.68%

---

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -7.07% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| -5.01% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | News | $96.0 52K |

Health Technology

| 18.53% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -16.02% | O: 1.32% H: 0.31% C: 0.12%
PFE | News 4 | $26.185 -0.51% 6.6M |

Health Technology

| -30.77% | O: 0.6% H: 1.07% C: 0.29%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| -18.57% | O: -1.84% H: 1.62% C: 1.33%
NVS | News | $97.515 0.24% 820K |

Health Technology

| 1.8% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.64 -0.71% 2.3M |

Health Technology

| -24.26% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -6.33% | O: 1.05% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| -2.73% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

---

Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
Published: 2023-05-23 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| -5.14% | O: 0.7% H: 1.22% C: -0.67%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| -24.56% | O: -1.39% H: 0.06% C: -2.77%
JNJ | News | $147.27 -1.53% 2.3M |

Health Technology

| -4.6% | O: 0.15% H: 0.74% C: -0.18%
LLY | News | $731.46 -1.91% 700K |

Health Technology

| 70.29% | O: -0.25% H: 0.69% C: -2.24%
ABT | News | $105.9 -1.57% 1.3M |

Health Technology

| -0.61% | O: -0.88% H: 0.17% C: -1.45%
ORMP A | $2.35 7.7K |

Health Technology

| -46.95% | O: 0.9% H: 10.29% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| -4.84% | O: 0.97% H: 0.0% C: -1.46%
report global protein therapeutics growth market

---

Global Bioengineered Protein Drugs Markets Report 2023: A $521.3 Billion Market by 2027 Featuring AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi
Published: 2023-04-20 (Crawled : 01:00) - prnewswire.com
CMXHF | $176.0 50 |

n/a

| -12.22% | O: -1.07% H: 1.56% C: -0.01%
CSLLY | $90.71 35K |

n/a

| -9.87% | O: 0.23% H: 0.39% C: -0.18%
GLAXF | News | $19.54 2.6K |

Health Technology

| 5.62% | O: -0.08% H: 0.0% C: -0.68%
AZNCF | News | $140.3 1.5K |

Health Technology

| -5.06% | O: 0.42% H: 0.0% C: -0.53%
NVSEF | News | $96.0 52K |

Health Technology

| 17.55% | O: 0.61% H: 0.0% C: 0.0%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| -22.05% | O: 0.33% H: 0.36% C: -0.13%
NVS | News | $97.515 0.24% 820K |

Health Technology

| 0.86% | O: 0.34% H: 0.28% C: 0.25%
JNJ | News | $147.27 -1.53% 2.3M |

Health Technology

| -7.92% | O: -0.06% H: 0.86% C: 0.71%
GSK | News | $40.73 -1.24% 360K |

Health Technology

| 11.67% | O: -0.24% H: 0.0% C: -1.03%
ABBV | News | $168.1 -0.85% 670K |

Health Technology

| 5.17% | O: -0.02% H: 0.37% C: 0.35%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -15.45% | O: -0.03% H: 0.0% C: 0.0%
BNTX | News | $88.55 0.07% 62K |

Health Technology

| -27.34% | O: -0.85% H: 1.51% C: 0.15%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| -5.33% | O: 0.05% H: 0.11% C: -0.47%
AMGN | News | $273.6 0.02% 370K |

Health Technology

| 11.1% | O: -0.04% H: 0.11% C: -1.08%
ADMA 4 | $6.47 -1.07% 240K |

Health Technology

| 89.02% | O: -0.87% H: 1.17% C: 0.29%
report merck global protein sanofi market

---

Global Generic Drugs Strategic Business Report 2023: Market to Reach $644.5 Billion by 2030 from $402.9 Billion in 2022 - Patent Expiries in 2020, 2021 and 2022 Set to Widen the Addressable Market
Published: 2023-03-10 (Crawled : 00:20) - prnewswire.com
ENDP | News | $0.2926 -9.6% |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 480 |

Health Technology

| Email alert Add to watchlist
ABT | News | $105.9 -1.57% 1.3M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| Email alert Add to watchlist
GSK | News | $40.73 -1.24% 360K |

Health Technology

| Email alert Add to watchlist
BAX | $40.705 -0.77% 280K |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| Email alert Add to watchlist
LLY | News | $731.46 -1.91% 700K |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.5K |

Health Technology

| Email alert Add to watchlist
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.82 -1.82% 510K |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 2.6K |

Health Technology

| Email alert Add to watchlist
patent global report set market

---

Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 9.78% | O: 1.12% H: 0.0% C: -1.68%
SNYNF | News | $94.25 480 |

Health Technology

| -5.53% | O: -2.5% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| -2.32% | O: -1.16% H: 1.62% C: -0.54%
NVSEF | News | $96.0 52K |

Health Technology

| 25.97% | O: 0.05% H: 0.0% C: 0.0%
VTRS | News A | $11.34 -0.18% 900K |

Health Technology

| -4.05% | O: -0.17% H: 0.25% C: -2.96%
TMO | News | $568.365 -1.08% 680K |

Health Technology

| -3.81% | O: 0.56% H: 0.97% C: -1.87%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| -7.44% | O: 0.57% H: 0.84% C: -0.01%
NVS | News | $97.515 0.24% 820K |

Health Technology

| 7.01% | O: 0.93% H: 0.01% C: -1.16%
JNJ | News | $147.27 -1.53% 2.3M |

Health Technology

| -13.17% | O: -0.41% H: 0.2% C: -1.1%
GSK | News | $40.73 -1.24% 360K |

Health Technology

| 15.97% | O: -0.03% H: 0.17% C: -1.01%
LLY | News | $731.46 -1.91% 700K |

Health Technology

| 106.59% | O: -0.4% H: 0.75% C: -1.21%
ABT | News | $105.9 -1.57% 1.3M |

Health Technology

| -5.12% | O: -0.16% H: 0.33% C: -1.5%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -5.56% | O: -0.14% H: 0.0% C: 0.0%
BIIB | $202.05 4.59% 1.1M |

Health Technology

| -33.29% | O: 0.34% H: 0.46% C: -2.45%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 0.16% | O: 1.36% H: 0.33% C: -1.13%
AMGN | News | $273.6 0.02% 370K |

Health Technology

| 1.53% | O: 0.0% H: 0.41% C: -1.87%
therapy growth

---

Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 1.64% | O: -0.93% H: 3.08% C: 3.08%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| -5.94% | O: -0.89% H: 1.18% C: 0.52%
NVS | News | $97.515 0.24% 820K |

Health Technology

| 7.64% | O: -0.85% H: 0.2% C: -0.29%
JNJ | News | $147.27 -1.53% 2.3M |

Health Technology

| -16.92% | O: -0.62% H: 0.54% C: -0.12%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -4.45% | O: -3.07% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 1.94% | O: -0.49% H: 1.65% C: 0.94%
treatment patent global report growing diabetes growth market

---

Biosimilar Therapeutic Peptides Global Market to Reach $3.5 Billion by 2026 at a CAGR of 30.3%
Published: 2022-12-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| 6.08% | O: 0.74% H: 8.46% C: 8.46%
NVSEF | News | $96.0 52K |

Health Technology

| 27.69% | O: -1.97% H: 0.05% C: 0.05%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 1.23% | O: -0.85% H: 0.46% C: -0.17%
NVS | News | $97.515 0.24% 820K |

Health Technology

| 8.69% | O: 0.03% H: 0.26% C: -0.27%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| 4.65% | O: 0.33% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 3.55% | O: -0.48% H: 1.59% C: 0.69%
AMGN | News | $273.6 0.02% 370K |

Health Technology

| -3.99% | O: 0.33% H: 0.56% C: -0.89%
global biosimilar market

---

Oral Biologics & Biosimilars Global Market Report 2022: Drive to Create Insulin Biosimilars Presents Opportunities
Published: 2022-10-14 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| 24.74% | O: 6.95% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| 30.39% | O: 1.95% H: 1.5% C: 1.5%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 22.71% | O: 0.03% H: 0.35% C: -1.01%
GSK | News | $40.73 -1.24% 360K |

Health Technology

| 34.55% | O: 0.59% H: 0.66% C: -0.39%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| 20.95% | O: 2.74% H: 0.0% C: 0.0%
ENTX | $2.22 14K |

Health Technology

| 154.97% | O: 1.06% H: 0.01% C: -4.53%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 27.59% | O: 1.22% H: 0.52% C: -2.21%
RVP P | $1.085 1.4% 7.8K |

Health Technology

| -44.56% | O: -1.55% H: 8.42% C: 5.26%
global report insulin market

---

Pediatric Vaccine Global Market to Reach Over $57.5 Billion by 2026
Published: 2022-08-24 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 15.83% | O: -1.84% H: 0.0% C: -1.36%
SNYNF | News | $94.25 480 |

Health Technology

| 10.88% | O: -4.66% H: 0.0% C: -1.69%
AZNCF | News | $140.3 1.5K |

Health Technology

| 5.49% | O: 0.02% H: 0.0% C: -3.77%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -4.13% | O: -0.79% H: 0.98% C: 0.72%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 20.71% | O: 1.01% H: 2.53% C: 2.2%
GSK | News | $40.73 -1.24% 360K |

Health Technology

| 22.27% | O: -1.27% H: 0.99% C: 0.69%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| 14.96% | O: -1.48% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 6.65% | O: 0.11% H: 1.8% C: 1.71%
global vaccine market

---

Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study
Published: 2022-08-01 (Crawled : 10:00) - biospace.com/
IPHYF | $2.65 104.6% 300 |

Health Technology

| -16.14% | O: -14.87% H: 4.09% C: 4.09%
SNYNF | News | $94.25 480 |

Health Technology

| -6.63% | O: -3.9% H: 0.0% C: 0.0%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 9.77% | O: -0.21% H: 0.41% C: -0.73%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -5.84% | O: -1.92% H: 0.0% C: 0.0%
IPHA | $2.37 170 |

Health Technology

| -25.94% | O: -11.25% H: 0.0% C: -1.06%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 6.98% | O: 0.44% H: 0.53% C: -1.31%
pharma update study

---

Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 8.58% | O: -1.55% H: 4.43% C: 0.03%
PFE | News 4 | $26.185 -0.51% 6.6M |

Health Technology

| -48.13% | O: 1.46% H: 1.45% C: 0.78%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 15.05% | O: 0.72% H: 0.0% C: 0.0%
NVS | News | $97.515 0.24% 820K |

Health Technology

| 18.35% | O: 1.86% H: 1.05% C: 0.24%
JNJ | News | $147.27 -1.53% 2.3M |

Health Technology

| -16.97% | O: 0.78% H: 0.94% C: 0.26%
CCXI | News | $51.99 -0.04% |

Health Technology

| 87.83% | O: -4.88% H: 1.04% C: -1.25%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 6.54% | O: -0.36% H: 1.22% C: 0.38%
disease therapy growth

---

Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300 |

Health Technology

| -12.54% | O: 1.65% H: 0.0% C: -0.32%
SNYNF | News | $94.25 480 |

Health Technology

| -11.71% | O: -0.94% H: 0.0% C: 0.0%
NVO | News | $125.705 -2.28% 1.3M |

Health Technology

| 15.37% | O: 0.65% H: 0.63% C: 0.16%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -12.28% | O: -0.09% H: 0.0% C: 0.0%
IPHA | $2.37 170 |

Health Technology

| -19.99% | O: 2.96% H: 0.98% C: -1.15%
AZN | News | $70.93 0.11% 2.3M |

Health Technology

| 6.56% | O: -0.56% H: 0.82% C: -0.64%
iph5201 pharma cancer phase 2

---

Gainers vs Losers

57%

43%

Top 10 Gainers

CSSE 4 | $0.3686 142.02% 76M |

Consumer Services

CZOO | $11.685 134.17% 7.6M |

BOF | $1.93 64.96% 55M |

AMST | $3.14 57.0% 59M |

Technology Services

LICN | $0.7885 40.8% 11M |

TROO | $1.51 38.53% 5.6M |

Manufacturing

MULN | News | $3.7 35.53% 6.4M |

Information

WHLM | $6.61 30.12% 400K |

Commercial Services

RILY | $27.91 28.5% 8.9M |

Finance

RBBN 4 | $3.25 26.46% 1.5M |

Electronic Technology

---

Your saved searches

---